Impact of Substrate‐Based Ablation of Ventricular Tachycardia on Cardiac Mortality in Patients With Implantable Cardioverter‐Defibrillators

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 11, 2015-11 ,pp. : 1230-1238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Refining the Indications of Implantable Cardioverter Defibrillator in Patients with Left Ventricular Dysfunction

By  

Reviews on Recent Clinical Trials, Vol. 7, Iss. 3, 2012-08 ,pp. : 197-203

Bentham Science Publishers

Access to resources Recommend Favorite

Interruption of Pacing Following Nonsustained Ventricular Tachycardia in an AAI Programmed Implantable Cardioverter Defibrillator

By  

PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol. 38, Iss. 9, 2015-09 ,pp. : 1082-1090

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sleep-disordered breathing in patients with implantable cardioverter-defibrillator

By Grimm Wolfram   Apelt Sandra   Timmesfeld Nina   Koehler Ulrich  

EP-Europace, Vol. 15, Iss. 4, 2013-04 ,pp. : 515-522

Oxford University Press

Access to resources Recommend Favorite

Elevated

By Dichtl Wolfgang  

Wiener klinische Wochenschrift, Vol. 124, Iss. 1-2, 2012-01 ,pp. : 18-24

Springer Publishing Company

Access to resources Recommend Favorite